Cargando…

New Psychoactive Substances Consumption in Opioid-Use Disorder Patients

SIMPLE SUMMARY: We applied a toxicological screening on 187 urine samples collected from patients with opioid-use disorder treated with opioid agonists in Barcelona and Badalona addiction care services, Spain. We found that 27.3% of urine samples were positive for any type of new psychoactive substa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alías-Ferri, Maria, Pellegrini, Manuela, Marchei, Emilia, Pacifici, Roberta, Rotolo, Maria Concetta, Pichini, Simona, Pérez-Mañá, Clara, Papaseit, Esther, Muga, Robert, Fonseca, Francina, Torrens, Marta, Farré, Magí
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138226/ https://www.ncbi.nlm.nih.gov/pubmed/35625373 http://dx.doi.org/10.3390/biology11050645

Ejemplares similares

Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022)

Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers
por: Marchei, Emilia, et al.
Publicado: (2021)

Drug Interactions With New Synthetic Opioids
por: Pérez-Mañá, Clara, et al.
Publicado: (2018)

UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of Consumers
por: Pellegrini, Manuela, et al.
Publicado: (2020)

GC–MS/MS Determination of Synthetic Cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study
por: Nuñez-Montero, Melani, et al.
Publicado: (2023)

Non-allowed Pharmacologically Active Substances in Physical and Sexual Performance Enhancing Products
por: Pellegrini, Manuela, et al.
Publicado: (2017)

Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS
por: La Maida, Nunzia, et al.
Publicado: (2020)

Assessment of Unsuspected Exposure to Drugs of Abuse in Children from a Mediterranean City by Hair Testing
por: Pichini, Simona, et al.
Publicado: (2014)

New Psychoactive Substances: A Matter of Time
por: Pantano, Flaminia, et al.
Publicado: (2019)

Herbal Highs: Review on Psychoactive Effects and Neuropharmacology
por: Graziano, Silvia, et al.
Publicado: (2017)

EDITORIAL: New Psychoactive Substances (NPS), a New Global Issue: Neuropharmacological, Chemical and Toxicological Aspects
por: Pichini, Simona, et al.
Publicado: (2017)

Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers
por: Martínez-Riera, Roser, et al.
Publicado: (2019)

Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions
por: González, Débora, et al.
Publicado: (2015)

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users
por: Maida, Nunzia La, et al.
Publicado: (2021)

Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans
por: Papaseit, Esther, et al.
Publicado: (2021)

BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2022)

Molecular Insights on New Psychoactive Substances (NPSs)
por: Busardò, Francesco Paolo, et al.
Publicado: (2022)

Editorial: New Trends of Substance Abuse: Looking for New Psychotropic Effects of Chem Sex Drugs, Cognitive Enhancers, and New Psychoactive Substances
por: Pichini, Simona, et al.
Publicado: (2020)

Alcohol Induced Depression: Clinical, Biological and Genetic Features
por: Farré, Adriana, et al.
Publicado: (2020)

Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2019)

Cannabinoids: from pot to lab
por: Papaseit, Esther, et al.
Publicado: (2018)

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
por: Poyatos, Lourdes, et al.
Publicado: (2021)

Pharmacological effects of methylone and MDMA in humans
por: Poyatos, Lourdes, et al.
Publicado: (2023)

Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study
por: Martínez, Lucia, et al.
Publicado: (2021)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Role of Neonatal Biomarkers of Exposure to Psychoactive Substances to Identify Maternal Socio-Demographic Determinants
por: Jarque, Pilar, et al.
Publicado: (2021)

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
por: Busardò, Francesco Paolo, et al.
Publicado: (2021)

Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
por: Fuentes, Juan José, et al.
Publicado: (2020)

Abuse Potential of Cathinones in Humans: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2022)

Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis
por: Torres-Moreno, Mari Carmen, et al.
Publicado: (2018)

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
por: Pérez-Acevedo, Ana Pilar, et al.
Publicado: (2020)

The Tryptophan System in Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2020)

Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence
por: Mas, Marta, et al.
Publicado: (2022)

Recent Trends in Analytical Methods to Determine New Psychoactive Substances in Hair
por: Kyriakou, Chrystalla, et al.
Publicado: (2017)

Spontaneous Pneumothorax Secondary to Bullous Lung Emphysema Positive for Cannabinoids upon Toxicological Examination
por: Bisconti, Mario, et al.
Publicado: (2023)

Acute Pharmacological Effects of 2C-B in Humans: An Observational Study
por: Papaseit, Esther, et al.
Publicado: (2018)

Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries
por: Fonseca, Francina, et al.
Publicado: (2021)

Simultaneous determination of 24 opioids, stimulants and new psychoactive substances in wastewater
por: Bade, Richard, et al.
Publicado: (2019)

Mephedrone and Alcohol Interactions in Humans
por: Papaseit, Esther, et al.
Publicado: (2020)

Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH
por: Sprega, Giorgia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1sufttdoppouodcthffnqnpe59